Myeloma Master Class

OVERVIEW

This educational series is designed to provide insights and guidance on the critical and challenging issues in multiple myeloma. Our approach is to examine the entire spectrum from bench to bedside by critically analyzing and challenging current practice.

SERIES OBJECTIVES  

1. Examine the applied and pragmatic questions, challenges and opportunities in multiple myeloma from the perspectives of payers, patients, clinicians and everyone in between.

2. Gain alignment on the key issues in the multiple myeloma community today and actions that need to be taken forward for meaningful solutions to improve patient outcomes.

SERIES TOPICS

Mastering the Needs of Regulatory, Payer and HTA in Multiple Myeloma:  The Role of Real-World Evidence and Clinical Trial Design

Adopting Patient-Centric Drug Development Strategies in Multiple Myeloma  

Mastering the Development of Cell and Gene Therapies in Multiple Myeloma

Investigating Precision Medicine Strategies in Treating Relapsed / Refractory Multiple Myeloma

Mastering the Development and Adoption of Diagnostic, Prognostic, Theranostic and Monitoring Tests in Multiple Myeloma